0001179110-22-001381.txt : 20220217
0001179110-22-001381.hdr.sgml : 20220217
20220217171812
ACCESSION NUMBER: 0001179110-22-001381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sagartz John E
CENTRAL INDEX KEY: 0001746201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23357
FILM NUMBER: 22649411
MAIL ADDRESS:
STREET 1: 19 WORTHINGTON ACCESS DRIVE
CITY: MARYLAND HEIGHTS
STATE: MO
ZIP: 63043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inotiv, Inc.
CENTRAL INDEX KEY: 0000720154
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 351345024
STATE OF INCORPORATION: IN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 2701 KENT AVE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
BUSINESS PHONE: 3174634527
MAIL ADDRESS:
STREET 1: 2701 KENT AVENUE
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906-1382
FORMER COMPANY:
FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC
DATE OF NAME CHANGE: 19970918
4
1
edgar.xml
FORM 4 -
X0306
4
2022-02-15
0
0000720154
Inotiv, Inc.
NOTV
0001746201
Sagartz John E
C/O INOTIV, INC.
2701 KENT AVENUE
WEST LAFAYETTE
IN
47906-1382
1
1
0
0
Chief Strategy Officer
Common Shares
2022-02-15
4
A
0
30000
0
A
678524
D
Common Shares
2022-02-17
4
P
0
2506
19.9516
A
681030
D
Represents an award of restricted stock units that may be settled only by delivery of an equal number of common shares. The units are subject to forfeiture and vest in equal installments of 6,000 shares on each of the first five anniversaries of the grant date, subject to continued employment, and in certain circumstances upon or following a change in control.
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.9111 to $19.96, inclusive. The reporting person undertakes to provide to Inotiv, Inc., any security holder of Inotiv, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Beth Taylor, attorney-in-fact for John E. Sagartz
2022-02-17